The process of taking a new drug from the laboratory to the pharmacy shelves includes several steps. Which step occurs first?

Correct answer: Scientific development

Explanation

The pharmaceutical development pipeline is a long process that begins with basic scientific research to identify a new molecular entity before moving on to legal protections and testing.

Other questions

Question 1

According to Appendix M, what is the duration of drug patent protection in Canada?

Question 2

What is the duration of the preclinical testing phase for a new drug as described in Appendix M?

Question 3

In the United States, what is the process called when a manufacturer seeks permission to begin clinical studies with human subjects, and which body administers it?

Question 4

How many healthy volunteers are typically recruited for Phase 1 clinical trials according to Appendix M?

Question 5

What is the primary purpose of a Phase 3 clinical trial?

Question 6

Which Canadian body regulates the prices that manufacturers can charge for prescription and nonprescription medicines?

Question 7

What was the key recommendation from the Institute of Medicine (IOM) regarding direct-to-consumer drug advertising in the U.S.?

Question 8

How are Natural Health Products (NHPs) regulated in Canada?

Question 9

In the Canadian drug scheduling system defined by NAPRA, what is a Schedule II drug?

Question 10

Which Canadian province has not adopted the national drug scheduling model defined by the National Pharmacy Regulatory Authorities (NAPRA)?

Question 11

What is the duration of drug patent protection in the United States according to Appendix M?

Question 12

In Canada, what is the application process called when seeking permission to begin clinical testing, and which body administers it?

Question 13

What is the typical number of patient volunteers enrolled in a Phase 2 clinical trial?

Question 14

What is the term for the ongoing assessment of a drug's safety and effectiveness after it has been marketed?

Question 15

In the United States, under which act are natural products classified as food products?

Question 16

What is a key feature of drug advertising regulation in Canada compared to the U.S.?

Question 17

According to the NAPRA model in Canada, which drug schedule corresponds to products available for open access in a pharmacy only, without a prescription?

Question 18

What is the primary purpose of a Phase 0 clinical trial?

Question 19

What is the purpose of the Common Electronic Submissions Gateway (CESG)?

Question 20

In Canada, what is required for all Natural Health Products (NHPs) before they can be sold?

Question 21

What is the typical range of patient volunteers for a Phase 3 clinical trial?

Question 22

In Canada, which schedule includes drugs that can be sold in any store without professional supervision?

Question 23

What is a major difference highlighted between the U.S. and Canada regarding potentially dangerous drugs like insulin and heparin?

Question 24

What is the primary purpose of a Phase 2 clinical trial?

Question 25

According to a study cited in Appendix M, approximately what percentage can U.S. citizens save if they buy their medications from Canadian pharmacies?

Question 26

After a drug's patent expires, what typically happens in the pharmaceutical market?

Question 27

Which entities are responsible for approving drug advertising in Canada?

Question 28

What is a major limitation placed on claims for natural products in the U.S. under the Dietary Supplements Health Education Act?

Question 29

In the U.S. pharmaceutical system, medications are categorized into which two general classes for accessibility?

Question 30

What does a Natural Product Number (NPN) issued by Health Canada signify?

Question 31

What is the primary objective of preclinical testing in the drug development process?

Question 32

In the Canadian drug scheduling system, a drug that is 'Available only by prescription and provided by a pharmacist' falls under which schedule?

Question 33

In Canada, who is responsible for deciding the schedule for individual drugs, with the exception of narcotics and controlled substances?

Question 34

How does the text describe the approval process for new drugs in both the U.S. and Canada?

Question 35

What is a Homeopathic Medicine Number (DIN-HM) used for in Canada?

Question 36

What is the defining characteristic of a Phase 3 clinical trial study design?

Question 37

What happens to the price of a drug after a patent expires and generic versions become available?

Question 38

What is a significant difference in the regulatory requirements for natural products between Canada and the U.S.?

Question 39

Which of the following best describes the term 'Over-the-Counter (OTC)' in the U.S. context?

Question 40

What is the primary focus of a Phase 1 clinical trial?

Question 41

In the Canadian pharmaceutical system, what does the term 'behind-the-counter' refer to?

Question 42

What is the main reason cited for the controversy surrounding direct-to-consumer drug advertising in the U.S.?

Question 43

Which of these is NOT a phase of clinical trials mentioned in Appendix M?

Question 44

What type of product is included under the term 'Natural Product' in Canada?

Question 45

What is the key difference between the U.S. and Canada regarding drug pricing controls?

Question 46

What is a major consequence of the different drug accessibility rules between the U.S. and Canada?

Question 47

In the Canadian system, a site license is required for what activity related to Natural Health Products?

Question 48

Why did the Institute of Medicine (IOM) recommend a temporary ban on direct-to-consumer advertising for new drugs?

Question 50

What is a key similarity between the US FDA and Health Canada regarding drug approval?